Clinical Trial Update: Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy [Phase 3]

View source ↗

Summary

Phase III trial evaluating Compound Danshen Dripping Pills for non-proliferative diabetic retinopathy is ongoing; no results or status details are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• Compound Danshen Dripping Pills

Snippet

Sponsor: Tasly Pharmaceuticals, Inc. | Conditions: Non-proliferative Diabetic Retinopathy | Phase 3 | Status: UNKNOWN